General Bioactive Libraries

General Bioactive Libraries cover nearly 20,000 known biologically active small molecules, including Bioactive Compound Library, Approved Drug Library, Clinical Compound Library, FDA-Approved Drug Library, and Featured Novel Bioactive Compound Library. They are suitable for drug repurposing, target identification, pharmacological studies and cell induced differentiation, and can be used for high-throughput and high-intensity screening.

Cat No.	product name
L4000	Bioactive Compound Library	A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;	14439 compounds
L1000	Approved Drug Library	A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);	2808 compounds
L9200	Drug Repurposing Compound Library	A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);	4630 compounds
L4150	Featured Novel Bioactive Compound Library	It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 989 compounds without compro	989 compounds
L3400	Clinical Compound Library	A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);	3404 compounds
L4010	Bioactive Compounds Library Max	A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.	22555 compounds
L4200	FDA-Approved Drug Library	A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);	1729 compounds

Cat No.

product name

L4000

Bioactive Compound Library

A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

14439 compounds

L1000

Approved Drug Library

A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);

2808 compounds

L9200

Drug Repurposing Compound Library

A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

4630 compounds

L4150

Featured Novel Bioactive Compound Library

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 989 compounds without compro

989 compounds

L3400

Clinical Compound Library

A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

3404 compounds

L4010

Bioactive Compounds Library Max

A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

22555 compounds

L4200

FDA-Approved Drug Library

A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

1729 compounds